Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19088048

Clin. Cancer Res. 2008 Dec 15 14 24 8302-7

Download in:

View as

Triples

General Info

PMID
19088048